Medifast (MED) Amortization of Deferred Charges (2016 - 2022)

Medifast (MED) has 5 years of Amortization of Deferred Charges data on file, last reported at $3000.0 in Q2 2022.

• For the quarter ending Q2 2022, Amortization of Deferred Charges changed N/A year-over-year to $3000.0; the trailing twelve-month figure through Mar 2023 stood at $3000.0 (down 99.27% YoY), and the FY2022 full-year result was $14000.0, down 84.27% from the prior year.
• Amortization of Deferred Charges for Q2 2022 stood at $3000.0, down from $11000.0 in the prior quarter.
• Across five years, Amortization of Deferred Charges topped out at $153000.0 in Q1 2018 and bottomed at $3000.0 in Q2 2022.
• The 3-year median for Amortization of Deferred Charges is $136000.0 (2018), against an average of $102000.0.
• Peak annual rise in Amortization of Deferred Charges reached 12.18% in 2018, while the deepest fall reached 21.39% in 2018.
• A 3-year view of Amortization of Deferred Charges shows it stood at $137000.0 in 2018, then retreated by 5.84% to $129000.0 in 2019, then slumped by 97.67% to $3000.0 in 2022.
• The last three Amortization of Deferred Charges figures came in at $3000.0 (Q2 2022), $11000.0 (Q1 2022), and $129000.0 (Q1 2019), per Business Quant data.

Peer Comparison